Treatments for immune systems disorders

Abstract

This invention provides methods and formulations for treating disorders of the immune system comprising administering a fortified formulation comprising stabilized rice bran derivative and a fortification agent. Preferred rice bran derivatives are rice bran oil and the solubilized fraction of rice bran. Preferred fortification agents are glucosamine derivative, methylsulfonylmethane, yucca concentrate, and grape seed extract.

1 - 47 . (canceled)  
     
     
         48 . A method for treating a disorder of the immune system in a mammal, said method comprising: 
 administering a fortified formulation comprising a stabilized rice bran derivative and at least one fortification agent, thereby treating said disorder in said mammal.    
     
     
         49 . The method of  claim 48 , wherein said stabilized rice bran derivative is a member selected from the group consisting of rice bran oil, enzyme-treated stabilized rice bran, a solubilized fraction, and a mixture thereof.  
     
     
         50 . The method of  claim 48 , wherein said fortification agent is a member selected from the group consisting of a glucosamine derivative, methylsulfonylmethane, yucca concentrate, and grape seed extract.  
     
     
         51 . A method for treating a disorder of the immune system in a mammal, said method comprising: 
 administering a fortified formulation comprising a stabilized rice bran derivative and at least one fortification agent, wherein said fortification agent is a member selected from the group consisting of a glucosamine derivative, methylsulfonylmethane, yucca concentrate, and grape seed extract, wherein said stabilized rice bran derivative is a member selected from the group consisting of rice bran oil, enzyme-treated stabilized rice bran wherein the enzyme is carbohydrate cleaving enzyme, a stabilized rice bran solubilized fraction, and a mixture thereof,    thereby treating said immune system disorder in said mammal.    
     
     
         52 . The method of  claim 48  or  51 , wherein said administering comprises ingestion of said fortified formulation.  
     
     
         53 . The method of  claim 48  or  51 , wherein said mammal is a member selected from the group consisting of a human, a horse, a cat, and a dog.  
     
     
         54 . The method of  claim 53 , wherein said disorder of the immune system is an autoimmune disease.  
     
     
         55 . The method of  claim 54 , wherein said autoimmune disease is selected from the group consisting of multiple sclerosis, type-1 diabetes mellitus, Graves' disease, systemic lupus erythematosus, scleroderma, psoriasis, intestinal bowel disease and celiac disease/gluten sensitivity.  
     
     
         56 . The method of  claim 55 , wherein said mammal is a human.  
     
     
         57 . The method of  claim 55 , wherein said disorder of the immune system is intestinal bowel disease, and wherein said formulation is ingested in the amount of about 2 grams to about 100 grams per day total.  
     
     
         58 . The method of  claim 48  or  51 , wherein said formulation is a member selected from the group consisting of a cream, a capsule, a bar, a powder, a food, a food supplement, a medical food, a liquid, a beverage, an emulsion or mixture thereof.